Shouqi Luo

568 total citations
14 papers, 342 citations indexed

About

Shouqi Luo is a scholar working on Genetics, Health, Toxicology and Mutagenesis and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shouqi Luo has authored 14 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 4 papers in Health, Toxicology and Mutagenesis and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shouqi Luo's work include Estrogen and related hormone effects (10 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Hormonal and reproductive studies (3 papers). Shouqi Luo is often cited by papers focused on Estrogen and related hormone effects (10 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Hormonal and reproductive studies (3 papers). Shouqi Luo collaborates with scholars based in Canada and United States. Shouqi Luo's co-authors include Alain Bélanger, Fernand Labrie, Claude Labrie, Antigone Sourla, Claude Labrie, Céline Martel, Yves Mérand, Sylvain Gauthier, Fernand Labrie and J.R. Selden and has published in prestigious journals such as Endocrinology, Antimicrobial Agents and Chemotherapy and International Journal of Cancer.

In The Last Decade

Shouqi Luo

14 papers receiving 329 citations

Peers

Countries citing papers authored by Shouqi Luo

Since Specialization

Citations

This map shows the geographic impact of Shouqi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shouqi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shouqi Luo more than expected).

Fields of papers citing papers by Shouqi Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shouqi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shouqi Luo. The network helps show where Shouqi Luo may publish in the future.

Co-authorship network of co-authors of Shouqi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shouqi Luo. A scholar is included among the top collaborators of Shouqi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shouqi Luo. Shouqi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models 2021 ·mAbs ·(unknown), Srimoyee Ghosh, Geeta Sharma, Zebin Wang, Marilyn R. Kehry, Margaret H. Marino, Tamlyn Y. Neben, Sharon Lu, Shouqi Luo, (unknown), Sridhar Ramaswamy, Hadi Danaee, David W. Jenkins	19
2	Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B 2008 ·Antimicrobial Agents and Chemotherapy ·Edward G. Bridges, J.R. Selden, Shouqi Luo	23
3	Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities 2001 ·Advances in protein chemistry ·Fernand Labrie, Claude Labrie, A. Bélanger, Vincent Giguère, Jacques Simard, Yves Mérand, Sylvain Gauthier, Van Luu‐The, Bernard Candas, Céline Martel, Shouqi Luo	20
4	Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050) 1998 ·Breast Cancer Research and Treatment ·Shouqi Luo, Claude Labrie, Alain Bélanger, Bernard Candas, Fernand Labrie	33
5	Effect of Twenty-Four-Week Treatment with the Antiestrogen EM-800 on Estrogen-Sensitive Parameters in Intact and Ovariectomized Mice 1998 ·Endocrinology ·Shouqi Luo, Antigone Sourla, Claude Labrie, Sylvain Gauthier, Yves Mérand, Alain Bélanger, Fernand Labrie	26
6	Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice 1997 ·International Journal of Cancer ·Shouqi Luo, Céline Martel, Sylvain Gauthier, Yves Mérand, Alain Bélanger, Claude Labrie, Fernand Labrie	19
7	Daily dosing with flutamide or casodex exerts maximal antiandrogenic activity 1997 ·Urology ·Shouqi Luo, Céline Martel, Cailin Chen, Claude Labrie, (unknown), Shankar M. Singh, Fernand Labrie	19
8	Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats 1997 ·International Journal of Cancer ·Shouqi Luo, Miloš Stojanović, Claude Labrie, Fernand Labrie	24
9	Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice 1997 ·International Journal of Cancer ·Shouqi Luo, Céline Martel, Antigone Sourla, Sylvain Gauthier, Yves Mérand, Alain Bélanger, Claude Labrie, Fernand Labrie	45
10	Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800 1997 ·Endocrinology ·Antigone Sourla, Shouqi Luo, Claude Labrie, Alain Bélanger, Fernand Labrie	35
11	Effect of Dehydroepiandrosterone on Bone Mass, Serum Lipids, and Dimethylbenz(a)anthracene-Induced Mammary Carcinoma in the Rat* 1997 ·Endocrinology ·Shouqi Luo, Claude Labrie, Alain Bélanger, Fernand Labrie	29
12	Combined Effects of Dehydroepiandrosterone and EM-800 on Bone Mass, Serum Lipids, and the Development of Dimethylbenz(A)Anthracene-Induced Mammary Carcinoma in the Rat* 1997 ·Endocrinology ·Shouqi Luo, Antigone Sourla, Claude Labrie, Alain Bélanger, Fernand Labrie	39
13	Comparative effects of 28‐day treatment with the new anti‐estrogen EM‐800 and tamoxifen on estrogen‐sensitive parameters in intact mice 1997 ·International Journal of Cancer ·Shouqi Luo, Céline Martel, Antigone Sourla, Sylvain Gauthier, Yves Mérand, Alain Bélanger, Claude Labrie, Fernand Labrie	3
14	Opposite Effects of Prolactin and Corticosterone on the Expression and Activity of 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4 Isomerase in Rat Skin 1994 ·Journal of Investigative Dermatology ·Jacques Couët, Céline Martel, Yvan Labrie, Shouqi Luo, Jacques Simard, Fernand Labrie	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact